[Therapeutic effectiveness of thiazolidinecarboxylate of arginine in psychiatric patients with hepatic disorders of toxic origin (alcohol, drugs)].
D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000009:adverse effects*; D001120:Arginine / Q000627:therapeutic use*; D002264:Carboxylic Acids / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy* / Q000209:etiology; D004338:Drug Combinations; D005260:Female; D006519:Hepatitis, Alcoholic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D013844:Thiazoles / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000009:adverse effects*
D000928:Antidepressive Agents; D002264:Carboxylic Acids; D004338:Drug Combinations; D013844:Thiazoles; D014149:Tranquilizing Agents; D001120:Arginine
Efficacia terapeutica del tiazolidincarbossilato di arginina in soggetti psichiatrici con disepatismo da cause tossiche (alcool, farmaci).